ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 44 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,194,820 | -25.8% | 8,611,375 | 0.0% | 0.00% | – |
Q3 2022 | $4,306,000 | -14.4% | 8,611,375 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $5,031,000 | -17.9% | 8,611,375 | 0.0% | 0.00% | – |
Q1 2022 | $6,131,000 | -46.1% | 8,611,375 | 0.0% | 0.00% | -100.0% |
Q4 2021 | $11,367,000 | -42.6% | 8,611,375 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $19,806,000 | -47.6% | 8,611,375 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $37,804,000 | -39.5% | 8,611,375 | 0.0% | 0.00% | -40.0% |
Q1 2021 | $62,519,000 | +18.2% | 8,611,375 | -29.7% | 0.01% | 0.0% |
Q4 2020 | $52,897,000 | +5.1% | 12,244,590 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $50,325,000 | -31.5% | 12,244,590 | 0.0% | 0.01% | -37.5% |
Q2 2020 | $73,468,000 | -20.3% | 12,244,590 | 0.0% | 0.01% | -38.5% |
Q1 2020 | $92,202,000 | -45.4% | 12,244,590 | -0.2% | 0.01% | -31.6% |
Q4 2019 | $168,755,000 | -30.4% | 12,273,064 | -39.9% | 0.02% | -34.5% |
Q3 2019 | $242,443,000 | -15.1% | 20,407,650 | 0.0% | 0.03% | -12.1% |
Q2 2019 | $285,503,000 | -21.8% | 20,407,650 | 0.0% | 0.03% | -25.0% |
Q1 2019 | $364,889,000 | +13.7% | 20,407,650 | 0.0% | 0.04% | 0.0% |
Q4 2018 | $321,012,000 | – | 20,407,650 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |